LIQUIDIA CORPORATION Amortization of Intangible Assets
LIQUIDIA CORPORATION (LQDA) reported Amortization of Intangible Assets of $100.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-12
- LIQUIDIA CORPORATION amortization of intangible assets for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- LIQUIDIA CORPORATION amortization of intangible assets for the quarter ending 2026-03-31 was $100.00K.
- LIQUIDIA CORPORATION amortization of intangible assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- LIQUIDIA CORPORATION amortization of intangible assets for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
- LIQUIDIA CORPORATION amortization of intangible assets for fiscal 2025 was $200.00K, a 33.33% decline from fiscal 2024.
- LIQUIDIA CORPORATION amortization of intangible assets for fiscal 2024 was $300.00K, a 0.00% change from fiscal 2023.
- LIQUIDIA CORPORATION amortization of intangible assets for fiscal 2023 was $300.00K, a 57.14% decline from fiscal 2022.
- LIQUIDIA CORPORATION amortization of intangible assets for fiscal 2022 was $700.00K, a 36.36% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $100.00K 10-Q · filed 2026-08-12 | $100.00K derived: sum of 3 quarters · filed 2026-08-12 | $200.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-11 | $100.00K derived: sum of 2 quarters · filed 2026-05-11 | $200.00K derived: sum of 3 quarters · filed 2026-05-11 | $300.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $100.00K derived: sum of 2 quarters · filed 2026-03-05 | $200.00K derived: sum of 3 quarters · filed 2026-08-12 | $200.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-03 | $200.00K derived: sum of 2 quarters · filed 2026-08-12 | $200.00K 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-12 | $100.00K 10-Q · filed 2026-08-12 | ||
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $200.00K derived: sum of 2 quarters · filed 2026-03-05 | $300.00K derived: sum of 3 quarters · filed 2026-03-05 | $300.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-03 | $200.00K derived: sum of 2 quarters · filed 2025-11-03 | $200.00K 10-Q · filed 2025-11-03 | $400.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-12 | $100.00K 10-Q · filed 2025-08-12 | $300.00K derived: sum of 3 quarters · filed 2026-03-05 | $400.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | $100.00K 10-Q · filed 2025-05-08 | $200.00K derived: sum of 2 quarters · filed 2026-03-05 | $300.00K derived: sum of 3 quarters · filed 2026-03-05 | $400.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $200.00K derived: sum of 2 quarters · filed 2026-03-05 | $300.00K derived: sum of 3 quarters · filed 2026-03-05 | $300.00K 10-K · filed 2026-03-05 |
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-13 | $200.00K derived: sum of 2 quarters · filed 2024-11-13 | $200.00K 10-Q · filed 2024-11-13 | $400.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-07 | $200.00K 10-Q · filed 2024-08-07 | $300.00K derived: sum of 3 quarters · filed 2024-08-07 | $500.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-13 | $200.00K derived: sum of 2 quarters · filed 2024-05-13 | $400.00K derived: sum of 3 quarters · filed 2024-05-13 | $600.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $300.00K derived: sum of 2 quarters · filed 2024-03-13 | $500.00K derived: sum of 3 quarters · filed 2024-03-13 | $700.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-07 | $400.00K derived: sum of 2 quarters · filed 2023-11-07 | $600.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $200.00K 10-Q · filed 2023-08-10 | $300.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $200.00K 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | $1.10M 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |